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A B S T R A C T
Three new 3-hydroxy-N-methyl-2-oxindole (1 and 2) and 4-hydroxy-pyran-2-one (3) derivatives, along with the
known 3-hydroxy-N-methyl-2-oxindole (4) and 6-methoxy-N-methylisatin (5) were isolated from a marine
Salinispora arenicola strain from sediments of the St. Peter and St. Paul Archipelago, Brazil. The structures of the
new compounds were elucidated by a combination of spectroscopic (1D and 2D NMR and HR-ESIMS) data,
including single-crystal X-ray diﬀraction analysis for 2 and 3. Compounds 1 to 5 were assayed for their anti-
microbial properties, but only 4 and 5 were active against Enterococcus faecalis with MIC value of 15.6 μg/mL.
1. Introduction
The genus Salinispora, formally described in 2005 by Maldonado
and co-workers as the ﬁrst obligate marine actinomycete [1], comprises
only the three species: S. tropica, S. paciﬁca, and S. arenicola [2]. These
bacteria are reported as an extraordinary source of unusual bioactive
secondary metabolites [3]. In fact, dozens of compounds structurally
diverse and unprecedented have been isolated from Salinispora species
as the salinosporamides [4,5], saliniquinones [6], arenicolides [7],
saliniketals [8], arenamides [9], salinipyrones, and paciﬁcanones
[10,11]. Interesting and relevant activities such as antibiotic [12,13],
anticancer [6,14], antimalarial [15], and immunosuppressant [16]
have been reported to the compounds isolated from Salinispora.
In the course of our study for bioactive natural compounds from
marine microorganisms [17–19], we have investigated the EtOAc ex-
tract of S. arenicola strain [20] from the sediments of Saint Peter and
Saint Paul Archipelago (ASPSP), an outlying group of islets located in
the Brazilian Atlantic ocean [21]. Herein the isolation and character-
ization of novel 4-hydroxy-pyran-2-one and 3-hydroxy-N-methyl-2-
oxindole derivatives are described. It is worth mentioning that this is
the ﬁrst report on the isolation of 2-oxindole derivatives from Salinis-
pora adding one more interesting class of compound to the genus.
Natural 3-substituted-3-hydroxy-2-oxindole derivatives have been iso-
lated from various sources, including plants [22,23], microorganisms
[24,25], and marine invertebrates [26]. Anti-cancer, anti-HIV, and
neuroprotective properties, including several modes of action has been
described for this class of natural compounds inspiring innumerous
organic synthesis using 3-hydroxy-2-oxindole frameworks as promising
scaﬀold for new drug discovery [27,28].
2. Experimental section
2.1. General procedures
Optical rotations were measured on a JASCO P-2000 digital po-
larimeter. IR spectra were recorded on Perkin-Elmer Spectrum 100
FTIR spectrometer NMR spectra were obtained either on a Bruker
Avance DRX-500 (500MHz to 1H and 125MHz to 13C), Avance DPX-
300 (300MHz to 1H and 75MHz to 13C) or Agilent DD2- 600 (600MHz
to 1H and 150MHz to 13C) spectrometers. High resolution electrospray
ionization mass spectra (HR-ESIMS) were acquired using on an Acquity
Xevo UPLC-QTOF-MS system from Waters (Milford, MA). Sephadex LH-
20 (Pharmacia) and SPE cartridges C18 (20 g/60mL; Strata,
Phenomenex) were used for the chromatographic fractionations. HPLC
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analyses were carried out using a UFLC (SHIMADZU) system equipped
with on an SPD-M20A diode array UV–Vis detector, a Phenomenex C-18
column, 5 μm (10.0× 250mm), and a CHIRALCEL OD-H chiral-phase
column, 5 μm (4.6× 150mm).
2.2. Bacterial material
The bacterial strain BRA-213, identiﬁed by Bauermeister et al. [29],
was isolated on solid A1 media (18 g of agar, 10 g of starch, 4 g of yeast
extract, and 2 g of peptone dissolved in 1 L of artiﬁcial seawater) from a
marine sediment collected around SPSPA, Pernambuco state-Brazil at a
depth of 16m (N 0°55′, W 29°38′) in November 2011. NCBIBLAST
analysis of the partial 16S rRNA sequence of strain BRA-213 (deposited
in GenBank with an accession number MH910695) is identical to S.
arenicola. A voucher strain BRA-213 is preserved at the Laboratory of
Marine Bioprospection and Biotechnology, Universidade Federal do
Ceará, Brazil. The license for collection was granted by Biodiversity
Authorization and Information, SisGen number AA8F8B8.
2.3. Fermentation
Colonies of the strain BRA-213 were inoculated into Erlenmeyer
ﬂasks (2 L) containing 500mL of A1 media (10 g of soluble starch, 4 g of
yeast extract, and 2 g of peptone in 1 L of artiﬁcial seawater) supple-
mented with calcium carbonate (0.5 g/L CaCO3), 5 mL of solutions of
iron (III) sulfate (8 g/L Fe2(SO4)3) and potassium bromide (20 g/L KBr).
On the second day, Sterile Amberlite XAD-16 resin (10 g) was added to
each ﬂask, and the cultures were shaken at 200 rpm at 28 °C for 14 days.
2.4. Extraction and isolation
The whole fermentation broth (20L) was ﬁltered through cheese-
cloth to separate the Amberlite XAD-16 resin, which was extracted with
acetone (3×300mL). The combined acetone fraction was distillated
under reduced pressure to yield a residual aqueous layer which was
further extracted with EtOAc (3×500mL). The resulting EtOAc frac-
tion was evaporated under reduced pressure to yield a crude organic
extract (9 g), which was fractionated on a C-18 SPE (9×1.0 g), car-
tridge and eluted with MeOH/H2O (7:3 and 8:2), and MeOH to give
three fractions (A-C). Fraction A (5 g) was chromatographed using a C-
18 SPE cartridge (5×1.0 g) and eluted with MeOH/H2O (3:7, 4:6, 5:5,
6:4, 7:3, and 8:2) and MeOH to give seven fractions (AA-AG). Fraction
AB (660mg) was fractionated by a Sephadex LH-20 column, eluted
with MeOH to give ﬁve subfractions (AB1-AB5). Subfraction AB3
(120mg) was puriﬁed by semipreparative HPLC (MeOH/H2O,
40–100%, 20min, ﬂow rate of 4.72mL/min) to provide the known
compounds 4 (6.8 mg, tR= 8.5min) and 5 (8.1 mg, tR= 12.5 min).
Subfraction AB4 (32mg) was also puriﬁed by semipreparative HPLC
(CH3CN/H2O, 50–100%, 30min, ﬂow rate of 3.00mL/min) to provide
compounds 1 (2.0 mg, tR= 5.5min), 2 (1.0 mg, tR= 6.0 min) and 3
(3.8 mg, tR= 6.6min).
3-Hydroxy-6-methoxy-3-(2-oxopropyl)-N-methyl-2-oxindole (1): yel-
lowish oil; [α]D22 + 16.3 (c 0.05, MeOH); IR (νmax) 3369, 2926,
2852, 1710, 1622, 1508, 1458, 1379, 1230, 1091, 833, 802,
717 cm−1; 1H and 13C NMR data, see Table 1; HR-ESIMS m/z
272.0905 [M+Na]+ (calcd for C13H15NNaO4, 272.0899).
5-Chloro-3-hydroxy-6-methoxy-3-(2-oxopropyl)-N-methyl-2-oxindole
(2): yellow crystals; [α]D22 + 94.1 (c 0.05, MeOH); IR (νmax) 3338,
2924, 2852, 1714, 1618, 1504, 1456, 1379, 1259, 1103, 1043, 798,
682 cm−1; 1H and 13C NMR data, see Table 1; HR-ESIMS m/z
284.0692 [M+H]+ (calcd for C13H15NO4Cl, 284.0690).
4-Hydroxy-6-(2-hydroxy-2-phenyl-1-methylethyl)-3-methyl-2H-pyran-
2-one (3): colorless crystals; [α]D22 - 7.8 (c 0.10, MeOH); IR (νmax)
3448, 2931, 2881, 1668, 1581, 1417, 1249, 1203, 1139, 1041, 964,
842, 756 cm−1; 1H and 13C NMR data, see Table 1; HR-ESIMS m/z
261.1123 [M+H]+ (calcd for C15H17O4, 261.1127).
3-Hydroxy-N-methyl-2-oxindole (4): pale powder; [α]D22 + 2.8 (c
0.05, MeOH); IR (νmax) 3346, 3027, 2927, 2851, 1697, 1627, 1517,
1462, 1380, 1270, 1088, 832 cm−1; 1H and 13C NMR data; HR-
ESIMS m/z 194.0817 [M+H]+ (calcd for C10H12NO3, 194.0816).
6-Methoxy-N-methylisatin (5): bright orange needles; IR (νmax) 3076,
2926, 2849, 1738, 1720, 1614, 1517, 1482, 1368, 1245, 1096,
841 cm−1; 1H and 13C NMR data; HR-ESIMS m/z 192.0659
[M+H]+ (calcd for C10H10NO3, 192.0661).
2.5. X-ray crystallographic analyses of compounds 2 and 3
The single-crystal X-ray intensity data of compounds 2 and 3 were
measured on a Bruker D8 Venture equipped with a microfocus Mo
generator (λKα=0.71073 Å) and a Photon II CMOS detector. The
frames were integrated with the Bruker SAINT software package
(v8.34A) using a narrow-frame algorithm. The ﬁnal cell parameters for
each crystal were based upon the reﬁnement of the XYZ-centroids of
some reﬂections. Data were corrected for absorption eﬀects using the
Multi-Scan method. The structure was solved using Olex2 [30], with the
ShelXT [31] structure solution program using Charge Flipping or Direct
Methods and reﬁned with the ShelXL [32] reﬁnement package using
Least Squares minimization. Olex2 was also used to prepare the crys-
tallographic information ﬁle (CIF). The program ORTEP-III (version
1.0.3) [33] was used to prepare the artwork representations for pub-
lication.
Crystal data of compound 2: Yellow prism crystals of compound 2
were obtained from an acetone solution after slow evaporation in a
refrigerator for 2 weeks. C15H13NO4Cl, Mr = 283.70 gmol−1; size
0.512×0.227×0.081mm; monoclinic, space group P2/c,
a=7.9022(8) Å, b=10.6193(10) Å, c=15.9197(14) Å, α=90°,
β=95.065(4) °, γ=90°; V=1330.7(2) Å3, Z=4,
ρcalc = 1.416 g cm−3, μ (Mo Kα)= 0.71073 cm−1, multi-scan,
transmin= 0.3958, transmax= 0.7457, F(000)= 592.0. The total
Table 1
1H and 13C NMR data assignment for compounds 1–3 (δ in ppm).
Position 1a 2b 3c
δC, type δH dδC, type δH δC, type δH
2 176.9, C 176.0, C 168.0, C
3 74.1, C 73.9, C 99.4, C
3a 121.9, C 121.8, C
4 125.0, CH 7.26 d
(8.1)
125.8, CH 7.37 s 169.3, C
5 106.8, CH 6.54 dd
(8.1, 2.1)
116.2, C 102.3, CH 6.08 s
6 161.8, C 156.7, C 166.1, C
7 97.0, CH 6.42 d
(2.1)
94.2, CH 6.46 s 47.4, CH 2.87, dq
(8.7, 7.0)
7a 145.2, C 143.7, C
8 49.2, CH2 2.94 d
(17.0)
48.7, CH2 2.94 d
(17.3)
77.1, CH 4.76, d
(8.7)
3.18 d
(17.0)
3.19 d
(17.3)
9 207.8, C 207.3, C 143.9, C
10 31.6, CH3 2.18 s 31.1, CH3 2.19 s 128.1, CH 7.33, m
11 129.5, CH 7.33, m
12 129.0, CH 7.28, m
15 8.4, CH3 1.87, s
16 15.6, CH3 0.96, d
(7.0)
N-CH3 26.5, CH3 3.19 s 26.4, CH3 3.22 s
O-CH3 55.8, CH3 3.83 s 56.4, CH3 3.96 s
a Compound 1 (CDCl3, 300MHz).
b Compound 2 (CDCl3, 600MHz).
c Compound 3 (CD3OD, 300MHz).
d Chemical shift deduced from the HSQC and HMBC experiments.
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number of reﬂections were 19,852 (−10≤ h≤ 10, −14≤ k≤ 14,
−21≤ l≤ 21) measured in the range 5.138°≤ 2Θ≤ 56.308°,
completeness Θmax= 100.0%, 3268 unique (Rint = 0.0890,
Rsigma= 0.0651) which were used in all calculations; Final indices:
R1obs= 0.0566, wR2obs= 0.1293 [I≥ 2σ(I)]; R1all = 0.0881,
wR2all = 0.1464 [all data], GOOF=1.033, largest diﬀerence peak
and hole 0.36/−0.27 e Å−3.
Crystal data of compound 3: Colorless crystals of compound 3 were
obtained from a methanol solution after slow evaporation in a re-
frigerator for 2 weeks. C15H16O4, Mr = 260.28 gmol−1; size
0.344×0.078×0.068mm; orthorhombic, space group P212121,
a=7.1897(6) Å, b=13.5319(10) Å, c=28.297(2) Å, α=90°,
β=90°, γ=90°; V=2753.3(2) Å3, Z=8, ρcalc = 1.256 g cm−3, μ
(Mo Kα)= 0.71073 cm−1,multi-scan, transmin= 0.6947,
transmax= 0.7471, F(000)= 1104.0. The total number of reﬂections
were 29,289 (−9≤ h≤ 9, −18≤ k≤ 14, −37≤ l≤ 37) mea-
sured in the range 5.84°≤ 2Θ≤ 56.574°, completeness
Θmax= 100%, 6819 unique (Rint = 0.0832, Rsigma= 0.0585) which
were used in all calculations; Final indices: R1obs= 0.0516,
wR2obs= 0.1116[I≥ 2σ(I)];R1all = 0.1015, wR2all = 0.1368 [all
data], GOOF=1.000, Flack parameter=−0.6(8), largest diﬀer-
ence peak and hole 0.175/−0.152 e Å−3.
The crystallographic data for compounds 2 and 3 has been de-
posited to the Cambridge Crystallographic Data Center as supplemen-
tary publication no. CCDC 1847811 and 1,847,809, respectively. Copies
of the data are available online free of charge at http://www.ccdc.cam.
ac.uk (or from CCDC, 12 Union Road, Cambridge CB2 1EZ, e-mail:de
posit@ccdc.cam.ac.uk, fax: +44–1223-336,033).
2.6. Antimicrobial assay
The antibacterial activity of the compounds 1–5was assayed on four
Gram-positive bacteria: Staphylococcus aureus (ATCC 29213),
Methicillin-Resistant Staphylococcus aureus (ATCC 43300, MRSA),
Enterococcus faecalis (ATCC 29212) and Vancomycin-Resistant
Enterococcus faecalis (ATCC 51212, VRE), and on the Gram-negative
Escherichia coli (ATCC 25922). Initially, the strains were previously
seeded in Petri dishes containing Mueller Hinton agar (Difco™), which
were incubated for 24 h at temperature of 35 ± 2 °C, under aerobic
conditions. Posteriorly the isolated colonies were collected and sus-
pended in sterile saline solution (NaCl 0.85% (w/v)). This suspension
was then used to obtain the bacterial inoculum in Mueller Hinton Broth
-MHB (Difco™) with ﬁnal bacterial concentration of 5× 105 CFU/mL.
The method used was broth microdilution in 96-well plate, and the
minimum inhibitory concentrations (MICs) of the substances was de-
termined according to Clinical Laboratory Standards Institute [34].
Rifampicin was used as positive control. The microplates were in-
cubated at same conditions cited above and the MIC was determined
after observation of the absence of bacterial growth in the culture
medium.
3. Results and discussion
Five compounds (1–5) were isolated from the EtOAc extract ob-
tained in the fermentation broth of a marine bacterial strain of S. are-
nicola. The structures of compounds 1–5 were established by a combi-
nation of their 1D and 2D NMR, HR-ESIMS spectroscopic data, and
single-crystal X-ray diﬀraction analyses, including comparison with
previously published data of analogous compounds, as described below
(Fig. 1).
Compound 1 was isolated as a yellowish oil. Its molecular formula
was assigned as C13H15NO4 based on the [M+Na]+ ion peak at m/z
272.0905 (calcd m/z 272.0899) by HR-ESIMS. The 1H NMR spectrum
exhibited signals at δH 7.26 (d, J=8.1 Hz, H-4), 6.54 (dd, J=8.1,
2.1 Hz, H-5) and 6.42 (d, J=2.1 Hz, H-7), typical of benzene ring AMX
system. In addition, it also displayed signals for methylene diaster-
eotopic protons at δH 3.18 (d, J=17.0 Hz, H-8b) and 2.94 (d,
J=17.0 Hz, H-8a), and one methyl group at δH 2.18 (s) characteristic
of a 2-oxopropyl group, as well as two singlets at δH 3.83 (s) and 3.19
(s) corresponding to one OCH3 and one NCH3, respectively. The 13C
NMR spectrum showed signals to 13 carbon atoms which were classi-
ﬁed, from the DEPT and HSQC spectra, as three methyl, one methylene,
three sp2 methines, and six non‑hydrogenated carbons, two of which
corresponding to the carbonyls at δC 207.8 (C-9) and 176.9 (C-2)
(Table 1). These data were consistent with the structure of 3-hydroxy-
N-methyl-2-oxindole derivative. In fact, except for the 2-oxopropyl
moiety the 1H and 13C NMR data of 1 were similar to those of 3-hy-
droxy-6-methoxy-N-methyl-2-oxindole (4), previously synthetized by
Chen and co-workers [35]. The unequivocal position of the 2-oxopropyl
substituent at C-3 was inferred by the HMBC correlations of the dia-
stereotopic protons H-8a and H-8b with the carbon signals at δC 176.9
(C-2), 121.9 (C-3a) and 74.1 (C-3). (Fig. 2). Based on the aforemen-
tioned data, the structure of 1 was established as 3-hydroxy-6-methoxy-
3-(2-oxopropyl)-N-methyl-2-oxindole. It is interesting to note that nat-
ural 3-substituted-3-hydroxy-2-oxindole derivatives bearing an un-
common 2-oxopropyl moiety was previously isolated from the marine
Bryozoan Amanthia convolata [26].
Compound 2 was isolated as yellow crystals, and its molecular
formula of C13H14NO4Cl was deﬁned based on HR-ESIMS whose spec-
trum displayed a protonated [M+H]+ molecular ion at m/z 284.0692.
Its 1H NMR spectrum exhibited signals for two para-positioned protons
at δH 7.37 (s, H-4) and 6.45 (s, H-7), two methylene diastereotopic
protons at δH 3.19/2.94 (d, J=17.3 Hz, 2H-8), and three methyl
groups (-OCH3, N-CH3 and –COCH3) evidencing a structure similar to
that of 1, but bearing a chlorine atom as substituent at C-5. As expected,
the 13C NMR data of 2 were similar to that observed for 1 (Table 1). The
diﬀerence in the chemical shifts of 2 when compared to 1 was found to
be in the aromatic ring due the replacement of a hydrogen atom by a
chlorine atom at C-5 (δC 116.2), corroborating with the observed para-
positioned protons in the 1H NMR spectrum. In addition, the complete
structure of 2 was conﬁrmed by a single-crystal X-ray diﬀraction ana-
lysis (Fig. 3) as 5-chloro-3-hydroxy-6-methoxy-3-(2-oxopropyl)-N-me-
thyl-2-oxindole.
Compound 3, colorless crystals, had its molecular formula C15H16O4
deduced through the protonated [M+H]+ ion at m/z 261.1123 (calcd
261.1127) observed by HR-ESIMS. The 1H NMR spectrum displayed
signals for a monosubstituted benzene ring at δH 7.28–7.33 (m, 5H), an
oleﬁnic proton at δH 6.08 (s, H-5), an oxymethine proton at δH 4.76 (d,
Fig. 1. Chemical structures of compounds 1–5.
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J=8.7 Hz, H-8) and a methine 2.87 (dq, J=8.7 and 7 Hz, H-7), in
addition to two methyl groups at δH 1.87 (s, H-15) and 0.96 (d,
J=7.0 Hz, Me-16). The 13C NMR spectrum exhibited 15 carbon signals
deﬁned, through APT spectra, as two methyl, eight methines, and ﬁve
sp2 non‑hydrogenated carbons, including one extended conjugated
lactone carboxyl at δC 168.0 (C-2) and two oxygenated sp2 carbons at δC
169.3 (C-4) and 166.1 (C-6) (Table 1). These data led to the suggesting
of a structure for a 4-hydroxy-pyran-2-one derivative, similar to a
known tetraketide, previously isolated from a mutant strain of Amyco-
latopsis mediterranei [36], but bearing a non-substituted aromatic ring
instead of a hydroxylated ring as the above-mentioned tetraketide and
conﬁrmed by 2D NMR as showed in Fig. 2. The dipolar interaction of
the methyl protons at δH 0.96 (Me-16) with the oxymethine proton at
δH 4.76 (H-8) indicated an anti-positioning of both the Me-16 and HO-8,
as observed previously for similar compounds [36]. The unequivocal
structure of 3 were conﬁrmed by a single-crystal X-ray diﬀraction
analysis (Fig. 4). Thus, the structure of 3 was established as 4-hydroxy-
6-(2-hydroxy-2-phenyl-1-methylethyl)-3-methyl-2H-pyran-2-one.
In addition to 1–3, the known compounds 3-hydroxy-N-methyl-2-
oxindole (4), and 6-methoxy-N-methylisatin (5) were also isolated.
Despite the very simple NMR data suggesting that compound 4 was
pure enough, the very low value of its [α]D22 required a further analysis
by HPLC using a chiral-phase column (Fig. S23 in Supplementary ma-
terial). Indeed, two peaks in a 1:2 ratio were observed, what is in
agreement with a scalemic mixture. Compound 4 had been described as
a synthetic product [35] and this study is the ﬁrst report of its isolation
as a natural source, while 5 was solely isolated from the plant Boronella
koniambiensis (Rutaceae) [37].
The antibacterial activity of compounds 1 to 5 were assayed against
Gram-positive (Enterococcus faecalis and Staphylococcus aureus) and
Gram-negative (Escherichia coli) bacteria strains, but only 4 and 5 were
active showing susceptibility on E. faecalis with MIC value of 15.6 μg/
mL (Table S1 in Supplementary material).
4. Conclusions
One new 4-hydroxy-pyran-2-one and two new 3-hydroxy-N-methyl-
2-oxindole derivatives were isolated from S. arenicola. A similar tetra-
ketide was previously isolated from a marine mutant strain of
Amycolatopsis mediterranei, the rifamycin producer [36]. On the other
hand, isatins are putative compounds produced by higher plants
Fig. 2. Key COSY, HMBC and NOESY correlations of compounds 1–3.
Fig. 3. Asymmetric unit of the crystalline structure of compound 2.
Fig. 4. Asymmetric unit of the crystalline structure of compound 3.
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although there are some few examples from marine microorganisms
[38,39].
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